First Week of BBIO May 2026 Options Trading

Analysis of BridgeBio Pharma Inc. (BBIO) options presents two strategies: selling a $52.50 strike put for a $6.50 premium, yielding an effective acquisition cost of $46.00 with an 18.99% annualized return if the put expires worthless (63% probability); alternatively, a covered call strategy involves buying BBIO at $53.17 and selling a $57.50 strike call for $6.70, projecting a 20.74% total return if called away by May 2026 (45% probability of call expiring worthless, yielding a 19.33% annualized premium return). Both strategies leverage an implied volatility of approximately 57%, slightly above the 52% trailing historical volatility, offering specific risk/reward profiles for investors.

Analysis

The article outlines two specific options strategies for BridgeBio Pharma Inc. (BBIO) leveraging elevated implied volatility. The first is a cash-secured put strategy, where selling the May 2026 $52.50 put contract for a $6.50 premium results in an effective acquisition cost of $46.00 per share, a notable discount from the current price of $53.17. This trade has a 63% probability of expiring worthless, which would generate an 18.99% annualized return on the cash commitment. The second strategy is a covered call, involving the purchase of shares at $53.17 and selling the May 2026 $57.50 call for a $6.70 premium. This caps the total return at 20.74% if the stock is called away, but offers a 19.33% annualized yield boost if the option expires worthless, an event with a 45% probability. A key insight is the discrepancy between the options' implied volatility of approximately 57% and the stock's trailing twelve-month historical volatility of 52%. This premium in implied volatility suggests that options are currently priced relatively richly, enhancing the potential returns for option sellers but also indicating market expectations for higher future price swings than observed over the past year.

Key Decisions for Investors

• Investors bullish on BBIO but seeking a more favorable entry point could consider selling the May 2026 $52.50 cash-secured put to either acquire the stock at an effective cost of $46.00 or generate an 18.99% annualized yield.
• Current or new shareholders aiming to generate income may find the covered call strategy attractive, selling the May 2026 $57.50 call to potentially achieve a 20.74% total return, while accepting a cap on further upside appreciation.
• Given that implied volatility at 57% exceeds historical volatility of 52%, selling options premium is quantitatively attractive, but this requires accepting the inherent risks, namely the obligation to purchase a potentially declining stock with the put or limiting gains with the call.